Data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial has found that daily aspirin use was associated with a 14% reduction in the incidence of prostate cancer. COMMENT: the meaning of this association is unknown as the data is still preliminary. Nevertheless, a daily aspirin can be very helpful in certain people at risk for heart disease. Daily usage should be discussed with your primary healthcare provider. Added benefits of daily aspirin is the possible reduction in colorectal polyps.

REF: Sakoda LC, Hayes RB, Huang WY, Peters U, Chatterjee N, Andriole GL, Church TR, Chia D, Hoover RN, Hsing AW, Use of aspirin and ibuprofen in relation to prostate cancer risk in a prospective study, P resented at American Association of Cancer Research (AACR), Orlando, FL, March 2004.

http://www3.cancer.gov/prevention/plco/

News Article: FAMILY PRACTICE NEWS, June 15, 2004, p.44